Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Laetitia A. Mauti"'
Autor:
Sabine Schmid, MD, Lisa Holer, MSc, Katrin Gysel, MSc, Kira-Lee Koster, MD, Sacha I. Rothschild, MD, Laura A. Boos, MD, Lorenz Frehner, MD, Sabine Cardoso Almeida, MD, Christian Britschgi, MD, PhD, Yannis Metaxas, MD, Michael Mark, MD, Patrizia Froesch, MD, Wolf-Dieter Janthur, MD, Anna Allemann, MD, Christine Waibel, MD, Catherine Von der Mühll-Schill, MD, Martin Früh, MD, Laetitia A. Mauti, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 12, Pp 100735- (2024)
Objectives: On the basis of the positive results of CheckMate-743, first-line (1L) treatment of malignant pleural mesothelioma (MPM) with the combination of ipilimumab and nivolumab (ipi-nivo) has become a standard-of-care. Furthermore, patients who
Externí odkaz:
https://doaj.org/article/eaf1ac72cdcf42a0a92d67407c36e4ea
Autor:
Jürgen Hetzel, Laetitia A. Mauti, Jonas Winkler, Sabine Cardoso Almeida, Philip Jermann, Miklos Pless, Lukas Bubendorf, Peter Karl Bode, Maik Häntschel
Publikováno v:
Journal of Clinical Medicine. 12:2355
Personalized treatment of metastatic non-squamous non-small cell lung cancer (NSCLC) requires detailed molecular characterization of the tumour including detection of predictive driver mutations and programmed death ligand 1 (PD-L1) expression. Compl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a975e0e0dfa236ff187ff63da073dd6
https://doi.org/10.3390/jcm12062355
https://doi.org/10.3390/jcm12062355
Autor:
Luciano Wannesson, Wolfram Jochum, H. Bouchaab, David König, Wolf-Dieter Janthur, Patrizia Frösch, Martin Früh, Alex Friedlaender, Sacha I. Rothschild, Laetitia A. Mauti, Alfredo Addeo, Izadora Demmer, Sämi Schär, Sabine Schmid, Christian Britschgi, Veronika Blum
Publikováno v:
Cancer Immunology, Immunotherapy. 69:1605-1613
Early clinical trials showed promising outcomes with immune-checkpoint inhibitors (ICI) in a subset of patients with relapsed small-cell lung carcinoma (SCLC). The aim of this retrospective analysis was to assess the efficacy and safety of ICI for re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca2c22ee7f3253deee38f335203e29bb
https://doi.org/10.1007/s00262-020-02565-0
https://doi.org/10.1007/s00262-020-02565-0
Autor:
Sacha I. Rothschild, Alfred Zippelius, Eric I. Eboulet, Spasenija Savic Prince, Daniel Betticher, Adrienne Bettini, Martin Früh, Markus Joerger, Didier Lardinois, Hans Gelpke, Laetitia A. Mauti, Christian Britschgi, Walter Weder, Solange Peters, Michael Mark, Richard Cathomas, Adrian F. Ochsenbein, Wolf-Dieter Janthur, Christine Waibel, Nicolas Mach, Patrizia Froesch, Martin Buess, Pierre Bohanes, Gilles Godar, Corinne Rusterholz, Michel Gonzalez, Miklos Pless, Swiss Group for Clinical Cancer Res Group
Publikováno v:
SSRN Electronic Journal.
Background: For patients with resectable stage IIIA(N2) non-small cell lung cancer (NSCLC) neoadjuvant chemotherapy with three cycles of cisplatin and docetaxel followed by surgery has been shown to yield a 1-year event-free survival (EFS) rate of 48
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12c18aa1447293402a94207100042f9c
https://doi.org/10.2139/ssrn.3759708
https://doi.org/10.2139/ssrn.3759708
Autor:
Laetitia A. Mauti, Bibhusal Thapa, Patrizia Froesch, Spasenija Savic, Thomas John, Martin Früh, Roger von Moos, Sacha I. Rothschild, Sabine Schmid, Tammo Bartnick, Walter Mingrone, Dirk Klingbiel, Ulf Petrausch, Y. Metaxas, Nick Pavlakis, Prudence A. Russell, Brett G.M. Hughes, Oliver Gautschi, Susanne Pratsch-Peter, Gareth Rivalland, Anna K. Nowak, Kenneth J. O'Byrne, Sibylle Wolleb, Hasna Bouchaab, Miklos Pless, Melanie Löffler-Baumann, Steven Kao
Publikováno v:
Journal of Thoracic Oncology. 13:1784-1791
Introduction There is no approved second-line treatment for malignant pleural mesothelioma (MPM). On the basis of promising early results, pembrolizumab was used off-label in Switzerland and Australia. We investigated outcomes in association with cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a9c785a013aa250f82c845b45d45cd1
https://doi.org/10.1016/j.jtho.2018.08.007
https://doi.org/10.1016/j.jtho.2018.08.007
Autor:
Miklos Pless, Sacha I. Rothschild, Alfred Zippelius, Tobias Finazzi, Laetitia A. Mauti, Martin Früh
Publikováno v:
memo - Magazine of European Medical Oncology. 11:122-131
Lung cancer is the leading cause of cancer-associated death worldwide. Traditionally, lung cancer is classified into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). While the prognosis of metastatic SCLC has remained dismal, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f236dd37597a927f705c3eb68dabe128
https://doi.org/10.1007/s12254-018-0411-3
https://doi.org/10.1007/s12254-018-0411-3
Autor:
Eugenio Fernandez, Alfredo Addeo, Nicolas Mach, Sacha I. Rothschild, Eric I. Eboulet, Laetitia A. Mauti, Martin Frueh, Michael Mark, Christine Waibel-Pachinger, Markus Joerger, Simon Haefliger, Gilles Godar
Publikováno v:
Journal of Clinical Oncology. 39:e21119-e21119
e21119 Background: A substantial proportion of patients with squamous lung cell carcinoma (SQCLC) (46%) exhibit tumor overexpression of fibroblast growth factor receptor (FGFR) messenger ribonucleic acid (mRNA). Rogaratinib is a novel pan-FGFR inhibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fb716285b728d7b6e848b1430bb5def
https://doi.org/10.1200/jco.2021.39.15_suppl.e21119
https://doi.org/10.1200/jco.2021.39.15_suppl.e21119
Publikováno v:
Praxis. 105:643-648
Zusammenfassung. Keimzelltumoren repräsentieren eine seltene Neoplasie, die meist Männer im Alter zwischen 15 und 40 Jahren betrifft. Zu etwa 50 % handelt es sich bei Hodenkarzinomen um reine Seminome, die 50 % Nicht-Seminome stellen eine heterogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5442c9983338fcaac8d80816a6c815a8
https://doi.org/10.1024/1661-8157/a002364
https://doi.org/10.1024/1661-8157/a002364
Autor:
T. Bartnick, Laetitia A. Mauti, Miklos Pless, Prudence A. Russell, Sabine Schmid, Anna K. Nowak, Kenneth J. O'Byrne, Brett G.M. Hughes, H. Bouchaab, Dirk Klingbiel, Thomas John, R. von Moos, Nick Pavlakis, O. Gautschi, Sacha I. Rothschild, S. Savic Prince, Gareth Rivalland, Y. Metaxas, S. Kao, Bibhusal Thapa
Publikováno v:
Annals of Oncology. 28:xi8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc6bac12101daba33ff7281f6ee23312
https://doi.org/10.1093/annonc/mdx711.007
https://doi.org/10.1093/annonc/mdx711.007
Autor:
S. Pratsch Peter, Laetitia A. Mauti, Sacha I. Rothschild, W. Mingrone, S. Wolleb Schild, Miklos Pless, Patrizia Froesch, R. von Moos, M. Loeffler, Ulf Petrausch, Y. Metaxas, H. Bouchaab, Sabine Schmid, S. Savic Prince, O. Gautschi, Dirk Klingbiel, T. Bartnick
Publikováno v:
Annals of Oncology. 28:v568
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d872db1840d85825cb68ccf066a509f
https://doi.org/10.1093/annonc/mdx389
https://doi.org/10.1093/annonc/mdx389